Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05070754 · ClinicalTrials.gov registry record · Phase 4
Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca
A Phase 4 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT05070754 is a Phase 4 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 17 participants.
The verdict
NCT05070754, a Phase 4 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
This study is going to test a cold atmospheric plasma device (CAP), in particular a floating electrode-dielectric barrier device (FE-DBD), to treat warts and molluscum. The treatment device in this study generates cold atmospheric plasma (gaseous ionized molecules) to rid the virus from the body. Based on the successes of previous dermatologic studies, FE-DBD is being tested for this study to treat warts and molluscum. Patients will be enrolled to test the efficacy and safety of this device. The duration of the study is 4-12 weeks depending on treatment clearance. The number of lesions will be chosen by the dermatologist. Patients will receive standard of care therapy and/or NTAP depending on the number of lesions.
Interventions
- DEVICE Cryotherapy
- DEVICE Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP)
- DRUG Canthardin Collodion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-12-02 |
| Est. Completion | 2022-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05070754
The ClinicalTrials.gov registry entry for NCT05070754 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cryotherapy is the first listed.
NCT05070754 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05070754 about?
NCT05070754 is a clinical study titled "Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca". This study is going to test a cold atmospheric plasma device (CAP), in particular a floating electrode-dielectric barrier device (FE-DBD), to treat warts and molluscum. The treatment device in this study generates cold atmospheric plasma (gaseous ionized molecules) to rid the virus from the body. Ba...
What is the current status of trial NCT05070754?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2021-12-02. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT05070754?
The interventions under investigation include: Cryotherapy (DEVICE), Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP) (DEVICE), Canthardin Collodion (DRUG).
Who is sponsoring clinical trial NCT05070754?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.